V. YAZISIZ Et Al. , "Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment," INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.64, no.1, pp.19-24, 2010
YAZISIZ, V. Et Al. 2010. Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.64, no.1 , 19-24.
YAZISIZ, V., Oenguet, G., Terzioglu, E., & Karayalcin, U., (2010). Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.64, no.1, 19-24.
YAZISIZ, VELİ Et Al. "Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment," INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.64, no.1, 19-24, 2010
YAZISIZ, VELİ Et Al. "Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment." INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.64, no.1, pp.19-24, 2010
YAZISIZ, V. Et Al. (2010) . "Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment." INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.64, no.1, pp.19-24.
@article{article, author={VELİ YAZISIZ Et Al. }, title={Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment}, journal={INTERNATIONAL JOURNAL OF CLINICAL PRACTICE}, year=2010, pages={19-24} }